MOTS-c Dosing Protocol
MOTS-c is a mitochondrial-derived peptide encoded by 12S rRNA, studied for metabolic regulation, exercise mimetic properties, and cellular energy optimization. It activates AMPK signaling and improves insulin sensitivity in research models.
Key Points
Step-by-Step Guide
Set Dose
Research protocols use 5-10 mg subcutaneously, administered 3-5 times per week. Some protocols use daily dosing during initial phases.
Time with Exercise
Administer 30-60 minutes before exercise sessions when possible. MOTS-c shows synergistic effects with physical activity through shared AMPK pathway activation.
Protocol Duration
Run 4-8 week cycles. The exercise-mimetic effects may take 2-3 weeks to become apparent. Combine with regular exercise for optimal results.
Monitor Metabolic Markers
Track fasting glucose, insulin sensitivity (HOMA-IR), body composition, and exercise performance metrics. MOTS-c primarily affects metabolic parameters.
Assess and Cycle
Evaluate at 8 weeks. Take 4-week breaks between cycles. Long-term continuous use has not been well studied.
Warnings & Precautions
- !Very limited human research data available.
- !Not FDA-approved for any indication.
- !Optimal dosing not established through clinical trials.
- !Cost is relatively high compared to other research peptides.
Frequently Asked Questions
What does MOTS-c do?
MOTS-c activates AMPK signaling, improving cellular energy metabolism, insulin sensitivity, and fat oxidation. It functions as an exercise-mimetic peptide derived from mitochondrial DNA.
Should MOTS-c be taken with exercise?
Combining MOTS-c with exercise produces synergistic benefits through shared AMPK pathway activation. Pre-exercise administration is the most common timing in research protocols.
How does MOTS-c compare to metformin?
Both activate AMPK, but through different mechanisms. MOTS-c is a naturally occurring peptide while metformin is a pharmaceutical. MOTS-c has far less clinical evidence but may offer more targeted mitochondrial effects.